Cervical Cancer
Conditions
Brief summary
incidence of detection of carcinogenic types of human papilloma virus in 60 cases of cervical cancer
Interventions
an observational analytical prospective cross-sectional study was managed from July 2019 to July 2022 on 70 cervical cancer patients collected from gyne-oncology unit in Shatby obstetrics and gynecology university hospital of Alexandria medical school after taking a written consent and following approval by Alexandria medical school institutional ethics committee. All patients were subjected to full history taking as age, gravidity, parity, contraceptive history, medical disease, detailed marital history and smoking. Collection of the sample from all cases of the study for human papilloma virus testing and genotyping was done after diagnostic workup and before treatment of the study cases at any time in post-menopausal women and at mid cycles period in premenopausal women by cervical smear using PAP spatula and endocervical brush.
Sponsors
Study design
Eligibility
Inclusion criteria
* cervical cancer
Exclusion criteria
* none
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Detection of human papilloma virus infections and genotyping using real time PCR | 10 days |
Countries
Egypt